Found 62 clinical trials
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
This is a phase 2, double-blind, randomized (1:1), placebo-controlled trial with two parallel groups. H56:IC31 (investigational vaccine) Placebo 900 HIV-negative adults with a diagnosis of drug susceptible pulmonary TB are planned to be included, recruited from TB clinics with established relationships to the trial sites at the start of their …
- 1 views
- 07 Oct, 2021
- 6 locations
Evaluation of the Feasibility, Accuracy, and Effect of a Rapid Point-of-Care Serological Triage Test for Active TB (SeroSelectTB) in High Burden, HIV-endemic African Settings: a Multi-centre, Parallel-group, Randomised, Controlled Trial (SeroSelectTB)
The performance of a new triage test for active tuberculosis (TB), SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition to stakeholders and regulatory authorities, and to support commercialization requirements. Consenting …
- 3 views
- 10 Oct, 2022
Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause
observational cohort study will be used for the study design. Questionnaires, pelvic examination, vaginal pap smear with maturation index (MI), vaginal pH, and other methods will be used to evaluate the
- 0 views
- 28 Oct, 2022
- 1 location
Steroids and Cross-linking for Ulcer Treatment
presenting to the Aravind Eye Care System (India), Kaiser Permanente Northern California (USA), or the University of California, San Francisco (USA) with smear-positive and/or culture-positive typical (i.e
- 0 views
- 09 Dec, 2021
- 4 locations
Immunological Mechanisms of Rejection in Uterine Transplantation (MARNI)
The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the …
- 0 views
- 04 Oct, 2022
- 1 location
Urinary Human Papilloma Virus Test in the General Population in Brittany (PapU-Access)
This is a population-based, prospective, multicenter and open-label study. 12,500 female non-respondents to the uterine cervix smear from 30 to 65 years of age in the context of the organized
- 0 views
- 04 Oct, 2022
- 1 location
Prevention and Screening Intervention Project - Towards Elimination of Cervical Cancer (PRESCRIP-TEC)
are offered Pap-smear and for women with Pap IV lis excision.
- 0 views
- 27 Oct, 2022
- 1 location
A Proximity-incentive Strategy for Cervical Cancer Screening (RIDECA)
In France, cervical cancer screening is based on a cervical smear for women aged 25 to 30 years and on High Risk- HPV (HR-HPV) testing for women aged 30 to 65 years. One of the main concerns in
- 0 views
- 25 Mar, 2022
Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial (RESISTE)
screening campaign based on the Pap smear. This approach has also just been validated by the French Health Authority which, in its public health recommendation dated 11 July 2019, states that "From
- 0 views
- 07 Oct, 2022
- 1 location
Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon (PCCCP)
identify cervical precancerous lesions. Current evidence shows that Human Papilloma Virus (HPV) testing is more effective than cytology (Pap smear) for cervical cancer screening in resource-limited
- 6 views
- 01 Feb, 2022
- 1 location